Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,064 Hematology
clinical trials

Hematology, Oncology Clinical Trial
IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Indiana University Melvin and Bren Simon Cancer Center
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Nivolumab and Tocilizumab for Relapsed Hematological Malignancy Post-allogeneic Transplant
Status: Enrolling, Phase I
Updated: 12/31/1969
Froedtert Hospital, Medical College of Wisconsin
1729
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical City Dallas Hospital
1224
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Mississippi Medical Center
1609
mi
from 91732
Jackson, MS
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital and Research Center Oakland
352
mi
from 91732
Oakland, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Jude Midwest Affiliate
1617
mi
from 91732
Peoria, IL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Mission Hospital-Memorial Campus
2002
mi
from 91732
Asheville, NC
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Children's Hospital Colorado
825
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Dayton Children's Hospital
1899
mi
from 91732
Dayton, OH
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Hackensack University Medical Center
2430
mi
from 91732
Hackensack, NJ
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Arkansas Children's Hospital
1463
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Wisconsin Hospital and Clinics
1654
mi
from 91732
Madison, WI
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Miami Miller School of Medicine-Sylvester Cancer Center
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
The Mayo Clinic
1524
mi
from 91732
Rochester, MN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Study Comparing Daratumumab, VELCADE (Bortezomib), Lenalidomide, and Dexamethasone (D-VRd) With VELCADE, Lenalidomide, and Dexamethasone (VRd) in Participants With Untreated Multiple Myeloma and for Whom Hematopoietic Stem Cell Transplant is Not Planned as Initial Therapy
Status: Enrolling, Phase III
Updated: 12/31/1969
Levine Cancer Institute
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjects With High-Risk Multiple Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Columbia University Medical Center and the New York Presbyterian Hospital
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of APVO436 in Patients With AML or MDS
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Utah, Huntsman Cancer Institute
573
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation
Status: Enrolling, Phase II
Updated: 12/31/1969
Stanford University School of Medicine
328
mi
from 91732
Stanford, CA
Click here to add this to my saved trials
Acute Myeloid Leukemia (AML) Clinical Trial
A Global Study of the Efficacy and Safety of Midostaurin + Chemotherapy in Newly Diagnosed Patients With FLT3 Mutation Negative (FLT3-MN) Acute Myeloid Leukemia (AML)
Status: Enrolling, Phase III
Updated: 12/31/1969
Oregon Health and Science University
827
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of Oral LOXO-305 in Patients With Previously Treated CLL/SLL or NHL
Status: Enrolling, Phase I, II
Updated: 12/31/1969
M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Levine Cancer Institute
2102
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Chronic Graft-Versus-Host-Disease Clinical Trial
Efficacy and Safety of KD025 in Subjects With cGVHD After At Least 2 Prior Lines of Systemic Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
Froedtert Hospital, Medical College of Wisconsin
1729
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Hematology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Enteral L Citrulline Supplementation in Preterm Infants - Safety, Efficacy and Dosing
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas Medical Branch
1399
mi
from 91732
Galveston, TX
Click here to add this to my saved trials
Hematology, Other Clinical Trial
Cerebrovascular Reserve and White Matter Disease in Patients With Chronic Anemia
Status: Enrolling, Phase
Updated: 12/31/1969
CHLA
16
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Univ of Rochester Medical Center
2244
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Seattle Cancer Care Alliance
962
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Study to Determine the Efficacy of Uproleselan (GMI-1271) in Combination With Chemotherapy to Treat Relapsed/Refractory Acute Myeloid Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
The Ohio State University Wexner Medical Center, James Cancer Hospital
1959
mi
from 91732
Columbus, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Safety Trial of Lisocabtagene Maraleucel (JCAR017) for Relapsed and Refractory (R/R) B-cell Non-Hodgkin Lymphoma (NHL) in the Outpatient Setting
Status: Enrolling, Phase II
Updated: 12/31/1969
Morristown Medical Center
2407
mi
from 91732
Morristown, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of PTC299 in Relapsed/Refractory Acute Leukemias
Status: Enrolling, Phase I
Updated: 12/31/1969
Columbia
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling, Phase
Updated: 12/31/1969
University of Colorado
820
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Hematology, Nephrology / Urology, Pulmonary / Respiratory Diseases, Reproductive Clinical Trial
Collection of Samples From Pregnant Women for the Evaluation of Preeclampsia (Pre-E) Biomarkers
Status: Enrolling, Phase
Updated: 12/31/1969
Regional Obstetrical Consultants
1854
mi
from 91732
Chattanooga, TN
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Participants With Acute Myeloid Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
962
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Status: Enrolling, Phase I
Updated: 12/31/1969
Northside Hospital
1918
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
Status: Enrolling, Phase I
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
Status: Enrolling, Phase I
Updated: 12/31/1969
Johns Hopkins University
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
Status: Enrolling, Phase I
Updated: 12/31/1969
Sarah Cannon Research Institute Tennessee Oncology
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Long-Term Follow-Up Study for Subjects Treated With P-BCMA-101
Status: Enrolling, Phase I
Updated: 12/31/1969
Univ of Pennsylvania
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Relapsed/Refractory Acute Myeloid Leukemia Clinical Trial
Study Evaluating Efficacy and Safety of CPI-613 in Combination With HD Cytarabine and Mitoxantrone vs HD Cytarabine and Mitoxantrone in Older Patients With R/R AML
Status: Enrolling, Phase III
Updated: 12/31/1969
Wake Forest Baptist Health
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Fabry Disease Clinical Trial
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of California, Irvine
33
mi
from 91732
Irvine, CA
Click here to add this to my saved trials
Fabry Disease Clinical Trial
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Utah, Division of Medical Genetics
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Phase II Study of the Combination of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin (MEGO) for Patients With Acute Myeloid Leukemia Refractory to Initial Standard Induction Therapy
Status: Enrolling, Phase II
Updated: 12/31/1969
UPMC - Hillman Cancer Center
2122
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Chronic Graft Versus Host Disease Clinical Trial
Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Hackensack University Medical Center
2430
mi
from 91732
Hackensack, NJ
Click here to add this to my saved trials
Coagulopathy Clinical Trial
Comparison of the Efficacy & Safety of Resusix With FP24 in Patients With Acquired Coagulopathy
Status: Enrolling, Phase II
Updated: 12/31/1969
University of Arizona
427
mi
from 91732
Tucson, AZ
Click here to add this to my saved trials
Hematology Clinical Trial
HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Site
2373
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Study Evaluating Safety, Tolerability and Clinical Activity of GSK2857916 in Combination With Pembrolizumab in Subjects With Relapsed/Refractory Multiple Myeloma (RRMM)
Status: Enrolling, Phase II
Updated: 12/31/1969
GSK Investigational Site
2100
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Massachusetts General Hospital
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
Status: Enrolling, Phase I, II
Updated: 12/31/1969
State University of NY
2436
mi
from 91732
Brooklyn, NY
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
Status: Enrolling, Phase I, II
Updated: 12/31/1969
UCLA Jonsson Comprehensive Cancer Center
25
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Thomas Jefferson University Hospital
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
A Study Evaluating the Safety and Efficacy of Idasanutlin in Combination With Cytarabine and Daunorubicin in Patients Newly Diagnosed With Acute Myeloid Leukemia (AML) and the Safety and Efficacy of Idasanutlin in the Maintenance of First AML Complete Remission
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Wake Forest Baptist Medical Center
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Regions Hospital
1517
mi
from 91732
Saint Paul, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
United Hospital
1515
mi
from 91732
Saint Paul, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Sainte Genevieve County Memorial Hospital
1579
mi
from 91732
Sainte Genevieve, MO
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint Francis Regional Medical Center
1493
mi
from 91732
Shakopee, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Southern Illinois University School of Medicine
1608
mi
from 91732
Springfield, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Mercy Saint Anne Hospital
1932
mi
from 91732
Toledo, OH
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pinometostat With Standard Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and MLL Gene Rearrangement
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Johns Hopkins University-Sidney Kimmel Cancer Center
2302
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Vanderbilt University Medical Center
1762
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Rady Children's Hospital - San Diego
101
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Hematology Clinical Trial
ATHN 8: PUPs Matter Study
Status: Enrolling, Phase
Updated: 12/31/1969
Children's Healthcare of Atlanta (Emory)
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Illinois CancerCare-Bloomington
1649
mi
from 91732
Bloomington, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Bozeman Deaconess Hospital
885
mi
from 91732
Bozeman, MT
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Illinois CancerCare - Carthage
1536
mi
from 91732
Carthage, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Univ of Illinois
1726
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
MetroHealth Med Ctr
2032
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Unity Hospital
1513
mi
from 91732
Fridley, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Great Falls Clinic
991
mi
from 91732
Great Falls, MT
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint Francis Hospital
2018
mi
from 91732
Greenville, SC
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint Francis Cancer Center
2022
mi
from 91732
Greenville, SC
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Kalispell Regional Medical Center
994
mi
from 91732
Kalispell, MT
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Minnesota Oncology Hematology PA-Maplewood
1521
mi
from 91732
Maplewood, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Saint John's Hospital - Healtheast
1521
mi
from 91732
Maplewood, MN
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Mercy Health Mercy Campus
1813
mi
from 91732
Muskegon, MI
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Illinois CancerCare - Pekin
1618
mi
from 91732
Pekin, IL
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Siteman Cancer Center-South County
1564
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Daunorubicin and Cytarabine With or Without Uproleselan in Treating Older Adult Patients With Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Park Nicollet Clinic - Saint Louis Park
1505
mi
from 91732
Saint Louis Park, MN
Click here to add this to my saved trials
AL Amyloidosis Clinical Trial
Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Columbia University Medical Center
2432
mi
from 91732
New York, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
A Post-Marketing Observational Study of VYXEOS™
Status: Enrolling, Phase
Updated: 12/31/1969
University of Maryland
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Hematology Clinical Trial
Volumetric Laser Endomicroscopy With Intelligent Real-time Image Segmentation (IRIS)
Status: Enrolling
Updated: 12/31/1969
North Shore University Hospital
2448
mi
from 91732
Manhasset, NY
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Cytarabine and Daunorubicin in Combination With Ruxolitinib for the Treatment of Secondary Acute Myeloid Leukemia Transformed From Myeloproliferative Neoplasms.
Status: Enrolling, Phase I, II
Updated: 12/31/1969
OHSU Knight Cancer Institute
826
mi
from 91732
Portland, OR
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry, Other Clinical Trial
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Memorial Sloan Kettering Cancer Center
2434
mi
from 91732
New York, NY
Click here to add this to my saved trials
Neutropenia Clinical Trial
International Registry for Severe Chronic Neutropenia
Status: Enrolling
Updated: 6/23/2005
St. Barnabas Medical Center
2416
mi
from 91732
Livingston, NJ
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study)
Status: Enrolling
Updated: 3/25/2016
University of California, School of Public Health, Childhood Leukemia Study
353
mi
from 91732
Berkeley, CA
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology Clinical Trial
Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases
Status: Enrolling, Phase II
Updated: 1/9/2014
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center
2294
mi
from 91732
Hershey, PA
Click here to add this to my saved trials
Hematology, Oncology, Orthopedics / Podiatry Clinical Trial
Long-term Evaluation and Follow-up Care of Patients Treated With Stem Cell Transplants
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases Clinical Trial
Apheresis to Obtain Plasma or White Blood Cells for Laboratory Studies
Status: Enrolling, Phase
Updated: 12/31/1969
National Institutes of Health Clinical Center, 9000 Rockville Pike
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Hematology, Nephrology / Urology, Oncology Clinical Trial
Laser Prostatectomy Database and Registry
Status: Enrolling, Phase
Updated: 12/31/1969
IU Health Methodist Hospital
1793
mi
from 91732
Indianapolis, IN
Click here to add this to my saved trials
Hemophilia A With Inhibitors Clinical Trial
A Prospective, Randomized, Cross-Over Study of an Activated Prothrombin Complex Concentrate for Secondary Prophylaxis in Patients With Hemophilia A and Inhibitors
Status: Enrolling, Phase II, III
Updated: 9/19/2005
Tulane University School of Medicine
1655
mi
from 91732
New Orleans, LA
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
2341
mi
from 91732
Anchorage, AK
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
1922
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
2277
mi
from 91732
Bethesda, MD
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
2100
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
2036
mi
from 91732
Cleveland, OH
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
819
mi
from 91732
Denver, CO
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
2433
mi
from 91732
Englewood, NJ
Click here to add this to my saved trials
Hypereosinophilic Syndrome Clinical Trial
This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic
Status: Enrolling, Phase
Updated: 12/31/1969
GSK Investigational Site
1400
mi
from 91732
Fargo, ND
Click here to add this to my saved trials
1 … 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 … 121